French Infrastructure Stock News

Quotient Sciences partnership extension and rare disease focus Ipsen (ENXTPA:IPN) is back in focus after extending its commercial supply partnership with Quotient Sciences to manufacture therapy for Fibrodysplasia Ossificans Progressiva, an ultra rare condition with highly specific treatment needs. The move includes Ipsen funding new equipment at Quotient Sciences' Boothwyn facility, aimed at handling highly potent compounds such as Sohonos and supporting commercial scale supply of multiple...

Getlink (ENXTPA:GET) has reported its FY 2025 results with second half revenue of €906 million and net income of €207 million, while the first half delivered €744 million of revenue and €113 million of net income, setting a clear earnings rhythm for the year. The company has seen half year revenue move from €806 million in the second half of 2024 to €906 million in the second half of 2025, alongside basic EPS of €0.26 in 2024 H2 and €0.21 in 2025 H1, giving investors a clear view of how top...

SEB (ENXTPA:SK) has wrapped up FY 2025 with second half revenue of €4.4b and basic EPS of €8.28, putting fresh numbers behind a year that also saw trailing twelve month revenue of €8.2b and EPS of €4.47. Over the past few periods, the group has seen revenue move from €4.5b in H2 2024 to €3.7b in H1 2025 and then €4.4b in H2 2025. Basic EPS shifted from €2.41 in H2 2024 to effectively flat at €0.01 in H1 2025 before rebounding to €8.28 in the latest half, leaving investors to weigh a low 1.6%...

Capgemini (ENXTPA:CAP) has just signed new deals with Deutsche Telekom and TELUS to advance network automation, alongside a partnership with OpenAI, which puts telecom and AI execution at the center of the stock story. See our latest analysis for Capgemini. Despite the fresh telecom and AI agreements, Capgemini’s recent share price performance has been weak, with a 30 day share price return of 18.67% and a year to date share price return decline of 24.01%. This has contributed to a 1 year...

Carrefour (ENXTPA:CA) posts FY 2025 results with weak first half but steadier trailing earnings picture Carrefour (ENXTPA:CA) has reported its FY 2025 numbers with a soft first half, booking €42.7b in revenue and a basic EPS loss of €0.56, while trailing twelve month figures point to revenue of €83.8b and EPS of €1.43. The company has seen first half revenue move from €41.4b with EPS of €0.04 in 2024 to €42.7b with an EPS loss in 2025, against a backdrop of trailing net profit margin sitting...

Publicis Groupe (ENXTPA:PUB) has moved to deepen its presence in retail media, with Publicis Media Middle East becoming the exclusive pilot agency partner for GoWit’s AI-driven GoWit One platform across the MENA region. See our latest analysis for Publicis Groupe. While the GoWit retail media deal, recent share repurchases and leadership changes in its media buying operations point to an active period for Publicis Groupe, the share price at €75.42 reflects a 30 day share price return of...

Compagnie de Saint-Gobain (ENXTPA:SGO) has drawn investor attention after recent share moves, with the stock showing mixed returns over the past week, month and past 3 months, prompting a closer look at its fundamentals. See our latest analysis for Compagnie de Saint-Gobain. At a share price of €86.86, Compagnie de Saint-Gobain’s recent 1-day and 7-day share price declines sit against a modest 30-day share price gain of 2.62%. Its 1-year total shareholder return decline of 6.44% contrasts...

Sanofi (ENXTPA:SAN) has received US FDA approval for Dupixent as the first treatment for allergic fungal rhinosinusitis (AFRS) in adults and children. The European Medicines Agency has issued a positive opinion for Acoziborole Winthrop, developed with DNDi, as a treatment for sleeping sickness. Sanofi plans to donate Acoziborole Winthrop to the World Health Organization for use in tackling this rare and neglected tropical disease. For you as an investor, these milestones highlight how...

Arkema (ENXTPA:AKE) has come into focus after releasing full year 2025 results, showing sales of €9,068 million and net income of €63 million, alongside an annual dividend announcement of €3.60 per share. See our latest analysis for Arkema. Arkema’s latest results and dividend decision come after a sharp 21.20% 1 month share price return to €61.45 and a 17.38% year to date share price gain. However, the 1 year total shareholder return of 18.76% and 5 year total shareholder return of 23.27%...

Vallourec (ENXTPA:VK) has drawn fresh attention after signing a Memorandum of Understanding with Baker Hughes, focused on integrating its Delphy underground hydrogen storage solution with Baker Hughes compression technology for green hydrogen projects. See our latest analysis for Vallourec. The recent hydrogen storage MOU sits alongside other developments, including a share buyback program and board changes involving ArcelorMittal representation. This comes during a period where Vallourec’s...

The UK's Commission on Human Medicines has issued updated recommendations on the prescribing information for Valneva's chikungunya vaccine, IXCHIQ. The changes refine restrictions on use in specific patient groups following earlier concerns about adverse events. The update affects how IXCHIQ can be used in the UK and reflects ongoing post marketing safety monitoring. For investors watching Valneva (ENXTPA:VLA), this regulatory update lands at a time when the shares trade around €4.69. The...

TotalEnergies (ENXTPA:TTE) has signed a preliminary 20 year LNG offtake agreement linked to the proposed Alaska LNG project. The company plans to purchase 2 million tons of LNG per year, with volumes targeted for customers in Asian markets. The arrangement is tied to a direct Pacific shipping route that aims to shorten transit times from Alaska to Asia. TotalEnergies is already active across the LNG value chain. This new agreement would add a North American source to its mix if the project...

Exosens (ENXTPA:EXENS) is back in the spotlight after reporting 2025 sales of €468.2 million and net income of €42.7 million, alongside new 2026 revenue guidance and a proposed €0.30 per share dividend. See our latest analysis for Exosens. The latest earnings beat, new 2026 revenue guidance and the proposed €0.30 dividend appear to be feeding into strong momentum, with a 30 day share price return of 15.99% and a 1 year total shareholder return of 151.14% at a €62.4 share price. If this kind...

Event driven interest in 2CRSI stock The Chemours Company and 2CRSI (ENXTPA:AL2SI) have signed a Joint Development Agreement focused on two phase immersion and direct to chip cooling for high density AI hardware, which ties the stock story closely to data center thermal management. See our latest analysis for 2CRSI. These cooling and AI infrastructure announcements have arrived during a period of sharp share price momentum for 2CRSI, with a 30 day share price return of 105.19% and a year to...

If you are wondering whether Orange’s share price still offers value after a strong run, you are not alone. This article will break down what the current price might be implying about the company. Orange recently closed at €17.84, with a 1 week return of a 1.7% decline, a 30 day return of 15.2% and a 1 year return of 64.8%. This naturally raises questions about how much of its potential is already reflected in the price and how risk is being priced in. Over the past few months, Orange has...

Thales (ENXTPA:HO) has released its 2026 Data Threat Report, focusing on risks linked to rapid AI adoption. The report finds that many enterprises now view AI as their top data security threat due to broad data access and limited controls. Findings highlight that current security practices often give AI systems more freedom over sensitive data than human users receive. For you as an investor or industry watcher, this matters because Thales is a major cybersecurity and digital identity...

Wondering whether Renault at €32.43 is offering value or just a value trap? This article will walk you through what the current price might be implying. Over the short term, the share price has moved by 0.8% over 7 days and 2.5% over 30 days. Yet year to date it is down 10.8% and the 1 year return sits at a 31.5% decline, with a 3 year return of 16.1% decline and a 5 year return of 9.1% decline. These mixed returns come against a backdrop of ongoing news around the global auto sector,...

Gaztransport & Technigaz (ENXTPA:GTT) has caught investor attention after its 2025 earnings release, a proposed higher cash dividend of €8.94 per share, and fresh 2026 revenue guidance in the €740 million to €780 million range. See our latest analysis for Gaztransport & Technigaz. At a share price of €192.2, recent momentum has been strong, with a 30 day share price return of 7.19% and a year to date gain of 23.76%. The 5 year total shareholder return of 240.60% points to a long term track...

Teleperformance SE has released its full-year 2025 results, reporting sales of €10,209 million and net income of €497 million, both slightly lower than the prior year, with basic earnings per share from continuing operations easing to €8.47. The simultaneous decline in both revenue and earnings raises questions about the resilience of Teleperformance’s operations just as investors focus on its longer-term AI- and automation-led plans. We’ll now examine how this recent dip in annual revenue...

Engie (ENXTPA:ENGI) has laid out a mixed picture for FY 2025 so far, with first half revenue of €38.1b and basic EPS of €1.16, against a backdrop where trailing 12 month revenue sits at €71.9b and EPS at €1.52. Looking back, revenue has moved from €37.5b in the first half of 2024 to €36.3b in the second half and then to €38.1b in the first half of 2025, while basic EPS has shifted from €0.78 to €0.88 and then to €1.16. This frames a story where investors are weighing improving profitability...

Why Carmila is on investors’ radar today Carmila (ENXTPA:CARM) has drawn attention after recent share price moves, with the stock showing positive returns over the past month and the past 3 months, prompting a closer look at its fundamentals. See our latest analysis for Carmila. Beyond the recent bounce, Carmila’s 30 day share price return of 11.6% and year to date share price return of 7.9% sit alongside a 1 year total shareholder return of 10.3%. Longer term total shareholder returns over 3...

Eutelsat Communications (ENXTPA:ETL) has completed a €1.5b senior notes offering. The company plans to use the proceeds to redeem existing notes and repay credit facilities. The transaction marks a significant step in reshaping Eutelsat Communications' debt profile. Eutelsat Communications operates in the satellite communications sector, serving video, data, and connectivity needs across different regions. For you as an investor, a large refinancing move of €1.5b is a meaningful event...

Technip Energies (ENXTPA:TE) is back in focus after securing major Engineering, Procurement, Construction and Commissioning contracts for QatarEnergy’s North Field West LNG project and the Coral Norte floating LNG project offshore Mozambique. See our latest analysis for Technip Energies. The latest QatarEnergy and Coral Norte wins arrive alongside a 1-day share price return of 4.04% and a 7-day share price return of 10.98%. The €37.6 share price sits against a 1-year total shareholder return...

Why Michelin’s Recent Share Move Has Caught Investor Attention Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) has seen its share price move in recent weeks, prompting investors to look more closely at its recent returns and fundamentals. The stock shows a 0.4% decline over the past day, alongside gains of 2.0% over the past week, around 11% over the past month, and about 21% over the past 3 months. This is drawing interest from readers tracking...